Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Receivables (2022 - 2025)

Historic Change in Receivables for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$1000.0.

  • Envoy Medical's Change in Receivables fell 12500.0% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13000.0, marking a year-over-year increase of 6388.89%. This contributed to the annual value of $604000.0 for FY2024, which is 24318.18% up from last year.
  • Envoy Medical's Change in Receivables amounted to -$1000.0 in Q3 2025, which was down 12500.0% from -$3000.0 recorded in Q2 2025.
  • Envoy Medical's Change in Receivables' 5-year high stood at $748000.0 during Q4 2024, with a 5-year trough of -$757000.0 in Q1 2025.
  • Over the past 4 years, Envoy Medical's median Change in Receivables value was -$2000.0 (recorded in 2025), while the average stood at -$3083.3.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 59259.26% in 2024, then plummeted by 42569.44% in 2025.
  • Quarter analysis of 4 years shows Envoy Medical's Change in Receivables stood at -$56000.0 in 2022, then surged by 292.86% to $108000.0 in 2023, then surged by 592.59% to $748000.0 in 2024, then crashed by 100.13% to -$1000.0 in 2025.
  • Its Change in Receivables was -$1000.0 in Q3 2025, compared to -$3000.0 in Q2 2025 and -$757000.0 in Q1 2025.